<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D9EFD5B9-6F3D-4279-8740-A4351E58710E"><gtr:id>D9EFD5B9-6F3D-4279-8740-A4351E58710E</gtr:id><gtr:name>Carl Zeiss AG</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/0EF04C8C-C002-40EC-9F06-6392FEBFBCBD"><gtr:id>0EF04C8C-C002-40EC-9F06-6392FEBFBCBD</gtr:id><gtr:name>PMT Hamamatsu Photonics K.K.</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>School of Medical Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D9EFD5B9-6F3D-4279-8740-A4351E58710E"><gtr:id>D9EFD5B9-6F3D-4279-8740-A4351E58710E</gtr:id><gtr:name>Carl Zeiss AG</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/0EF04C8C-C002-40EC-9F06-6392FEBFBCBD"><gtr:id>0EF04C8C-C002-40EC-9F06-6392FEBFBCBD</gtr:id><gtr:name>PMT Hamamatsu Photonics K.K.</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CB23B1D5-BFD3-4CA8-856C-5A2E1A6E1C75"><gtr:id>CB23B1D5-BFD3-4CA8-856C-5A2E1A6E1C75</gtr:id><gtr:name>Carl Zeiss Ltd</gtr:name><gtr:address><gtr:line1>509 Coldhams Lane</gtr:line1><gtr:postCode>CB1 3JS</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1EDCEB1C-C324-4860-9BAE-397B982E2464"><gtr:id>1EDCEB1C-C324-4860-9BAE-397B982E2464</gtr:id><gtr:name>Hamamatsu Photonics UK Ltd</gtr:name><gtr:address><gtr:line1>Hamamatsu Photonics UK Ltd</gtr:line1><gtr:line2>2 Gladbeck Way</gtr:line2><gtr:line3>Windmill Hill</gtr:line3><gtr:line4>Enfield</gtr:line4><gtr:postCode>EN2 7JA</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5B9542CC-D7F0-45DA-A423-16458386EA25"><gtr:id>5B9542CC-D7F0-45DA-A423-16458386EA25</gtr:id><gtr:name>GlaxoSmithKline PLC</gtr:name><gtr:address><gtr:line1>Park Road</gtr:line1><gtr:postCode>SG12 0DP</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1FF61108-E342-4618-805C-FFDCCB826C2F"><gtr:id>1FF61108-E342-4618-805C-FFDCCB826C2F</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Geoffrey</gtr:otherNames><gtr:surname>Spiller</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0C4B94B2-E44D-4063-A353-2D66100D8ABC"><gtr:id>0C4B94B2-E44D-4063-A353-2D66100D8ABC</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Loudon</gtr:surname><gtr:orcidId>0000-0003-3648-445X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5E5F2B27-7337-4D29-956E-CB97D8CB3FB8"><gtr:id>5E5F2B27-7337-4D29-956E-CB97D8CB3FB8</gtr:id><gtr:firstName>Dean</gtr:firstName><gtr:surname>Jackson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/416012ED-EFD3-45B1-A486-796B3C692CC8"><gtr:id>416012ED-EFD3-45B1-A486-796B3C692CC8</gtr:id><gtr:firstName>Claire</gtr:firstName><gtr:otherNames>Emma</gtr:otherNames><gtr:surname>Eyers</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/7A810E96-1EED-4E69-8577-38E7FF13C8C9"><gtr:id>7A810E96-1EED-4E69-8577-38E7FF13C8C9</gtr:id><gtr:firstName>Sascha</gtr:firstName><gtr:surname>Ott</gtr:surname><gtr:orcidId>0000-0002-5411-8114</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/ECF81483-494F-49C0-BA79-6EBA7EF83F0D"><gtr:id>ECF81483-494F-49C0-BA79-6EBA7EF83F0D</gtr:id><gtr:firstName>Till</gtr:firstName><gtr:surname>Bretschneider</gtr:surname><gtr:orcidId>0000-0002-5317-603X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C047998C-37DB-4DCE-98E1-A4BA02F0D930"><gtr:id>C047998C-37DB-4DCE-98E1-A4BA02F0D930</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>Richard</gtr:otherNames><gtr:surname>White</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B14A701D-B5D2-406C-9D53-66ADF1C6B239"><gtr:id>B14A701D-B5D2-406C-9D53-66ADF1C6B239</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Ray</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4A4A2C7D-88D7-40C2-89F3-0B8745F57660"><gtr:id>4A4A2C7D-88D7-40C2-89F3-0B8745F57660</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Alan</gtr:otherNames><gtr:surname>Rand</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5731DBB6-DFDC-4FE7-B421-916334A13C99"><gtr:id>5731DBB6-DFDC-4FE7-B421-916334A13C99</gtr:id><gtr:firstName>Pawel</gtr:firstName><gtr:otherNames>Wladyslaw</gtr:otherNames><gtr:surname>Paszek</gtr:surname><gtr:orcidId>0000-0002-0363-0716</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D21E59E6-E615-47C9-8867-2AEF290AD2C2"><gtr:id>D21E59E6-E615-47C9-8867-2AEF290AD2C2</gtr:id><gtr:firstName>B?rbel</gtr:firstName><gtr:otherNames>Frieda</gtr:otherNames><gtr:surname>Finkenst?dt</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/69187C9C-484F-4D86-9A77-2D8A098732D6"><gtr:id>69187C9C-484F-4D86-9A77-2D8A098732D6</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Muldoon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FK003097%2F1"><gtr:id>B330744F-B23C-4DDB-BAFA-02CC63B5136E</gtr:id><gtr:title>Systems Biology analysis of biological timers and inflammation</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/K003097/1</gtr:grantReference><gtr:abstractText>As we get older our immune system tends to get weaker and it becomes increasingly difficult to shake off diseases. At the same time we tend to develop arthritis and other auto-immune diseases which are localised instances of uncontrolled inflammation. In this grant application our multidisciplinary team of scientists consisting of physiologists, biologists, mathematicians and computer scientists aim to look at a very important signalling system NF-kappaB. This system plays an important role in stress and the immune responses and determines the fate of cells in the body, which is essential for general health and wellbeing. We will use a combined experimental and mathematical approach to analyse integrated systems that control NF-kappaB signalling in normal cells and tissues. 
We found that NF-kappaB carries signal information in the timing of its movements between the nucleus and cytoplasm. The timing of these movements determines which genes are switched on. We now wish to understand how this key process of NFkappaB signalling is controlled through normal life. How is it controlled by the cell division cycle, and how is it controlled by the sleep-wake cycle of the 24 h circadian clock.
Recently, we have found that the speed of the oscillations in the NF-kappaB signalling system are very temperature sensitive in the physiological and fever range between 35 and 40 degrees C. This also appears to markedly change the pattern of which genes are switched on or off. Our work so far has been in cell lines grown in the laboratory and we now wish to investigate NF-kappaB signalling in normal cells taken from transgenic mice that have fluorescently labelled NF-kappaB proteins. We will use these cells to determine the NF-kappaB response to temperature, a range of physiological stimuli including glucocorticoids (which are often used in inflammatory treatment), to screen small molecule drugs to find ones that modulate the response and to study the quantitative relationships with the cell cycle and the circadian clock. The data from these experiments and others published in the literature will be used to build integrated mathematical models that can predict important aspects of cell, tissue and animal physiology relevant to understanding the maintenance of a healthy organism and how this may change with age.
Key aims will be to understand how the clock and cell cycle together affect the timing and level of NF-kappaB signalling and which target genes are switched on. One of the NF-kappaB family of proteins, p105 encoded by the NFkB1 gene, has been found to cause faster ageing in mice when this gene is missing (Mann and von Ziglnicki, personal communication). We wish to investigate whether changes in NF-kappaB dynamics are involved in this ageing condition. Therefore, we will make a BAC reporter for p105 with fluorescent fusions at either end of the protein.
We are an ideal team to perform this work, because we have complementary interdisciplinary skills in cell imaging, image analysis, molecular cell biology, physiology, genomics, bioinformatics and mathematical modelling. A core part of the team has an excellent track record of working together to analyse the NF-kappaB signalling system. In addition, this new project brings in new team members with considerable expertise in animal physiology, circadian clocks and endocrinology.</gtr:abstractText><gtr:technicalSummary>We will develop a new quantitative understanding of coordinated inflammatory signalling in primary cells &amp;amp; tissues. We previously showed novel single-cell dynamics &amp;amp; function of the key inflammatory NF-kappaB signaling system in cell lines. This work has established a central hypothesis that coupling between multiple dynamic systems may allow different signals to be coordinated to ensure accurate &amp;amp; appropriate cell &amp;amp; tissue inflammatory responses. A key aim of this project is to understand process coordination between the NF-kappaB, circadian clock &amp;amp; cell cycle systems. Work will include 1) exploitation of transgenic models for NF-kappaB analysis system (using RelA &amp;amp; IkappaBalpha fluorescent BAC reporter mice) &amp;amp; the coupling with the circadian clock (cross with the Per2 luciferase reporter mice). 2) Analysis of the coupling between NF-kappaB, circadian clock &amp;amp; cell cycle in cell lines, primary cells &amp;amp; tissues using dynamic cell &amp;amp; single molecule imaging, quantitative proteomic &amp;amp; gene expression assays. 3) Perturbation analyses of system coordination using physiological stimuli, temperature, stimulation with glucocorticoids, disruption of clock (knockout &amp;amp; fast clock mutants) &amp;amp; a chemical screen to identify new agents that modulate NF-kappaB dynamics. 4) A key collaboration will be initiated with D. Mann &amp;amp; T. von Ziglnicki (Newcastle) to analyse NF-kappaB dynamics in NFKB1 KO that show an ageing phenotype. The theoretical work will produce new multi-scale deterministic &amp;amp; stochastic models to enable accurate predictions of temporal gene responses for a given input, thus providing new understanding of process coordination during inflammation. Modelling &amp;amp; experimental approaches will be used iteratively to direct experimental design. Our key aim is to provide new insights for understanding coupled biological systems that underlie the control of inflammation in cells &amp;amp; tissues in healthy &amp;amp; ageing organisms.</gtr:technicalSummary><gtr:potentialImpactText>The application of systems biology offers great potential for a better understanding of cell signalling and decision-making pathways. This in turn creates the opportunity for the identification of better drug targets and more efficacious modes of treatment of disease. This application is relevant to important processes in human and animal disease. In inflammation and innate immunity, NF-kappaB is a critically important regulator. The clock and cell cycle are important regulatory timing systems that control fundamental aspects of biology. This project is important for applied research and is of relevance to healthcare and to the pharmaceutical industry.
In this respect we have strong support for this project from GlaxoSmithKline (GSK, see letter from S. Farrow). They will assist us in conducting a new screen for small molecules that modulate the dynamics of NF-kappaB signalling (providing &amp;pound;20k pa of in kind support). GSK are also substantially supporting other work in the labs of A. Loudon and D. Ray. Until recently, M. White had an established collaboration with AstraZeneca (AZ) through Dr J. Unitt, who was a co-author on our major NF-kappaB papers. With the closure of AstraZeneca Charnwood this collaboration was put on hold. Recently AZ and GSK have each jointly funded the new &amp;pound;15m Manchester Collaborative Centre for Inflammation Research (MCCIR). It has been agreed by all involved that the present project would be affiliated to MCCIR. Following the likely appointment of a new Director in the next few weeks, it is anticipated that details of available in-kind support for the current project from the MCCIR will be formally agreed.
The major technologies being used in this project are based on bio-imaging. This is an important and currently growing area. We have close relationships with instrumentation companies and in particular with Carl Zeiss and Hamamatsu Photonics with whom MW has collaborated for 16 and 20 years respectively. This involves the loan and testi of equipment and the exchange of ideas, for new developments in microscopy and detection. Both companies will sponsor the project through support for the microscopy training courses in years 1,3 and 5 (the first course will be joint with the last SABR course thus saving on costs) The companies will provide speakers for the course from Germany and Japan, the loan of demonstration equipment and financial support. While the course is focused on providing training for the staff on the SABR project, places have been made available to staff on other systems biology projects from around the country. Representatives of each of the instrumentation companies are on the scientific advisory board for the BBSRC SABR project.
The use of microscopy generates movies and images that are colourful and visual. They represent an excellent resource for the development of public understanding of science. MW has given lectures at Public Understanding of Science meetings (e.g. ASE lecture in 2008). In 2006 a group from the CCI led by MW and DS, presented an exhibit entitled &amp;quot;The Language of Cells&amp;quot; at the Royal Society exhibitions in London, Glasgow and at Science Day at Buckingham Palace. The whole group are very keen apply to exhibit at future Royal Society exhibitions and this project may well give us a useful theme from which to develop a new exhibit. This offers a specific opportunity and we will seek others through talking to schools and other groups. When publicity of outcomes from this project are important, we will engage with the University of Manchester Press Office to coordinate this. We have good experience of media publicity and have previously worked with the BBSRC Press office in publicising high impact publications.</gtr:potentialImpactText><gtr:fund><gtr:end>2019-04-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2013-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>4160524</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>PMT Hamamatsu Photonics K.K.</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>Hamamatsu Photonics</gtr:description><gtr:id>F858F362-A93B-466D-AF52-C47B73DBBB44</gtr:id><gtr:impact>Annual training courses</gtr:impact><gtr:partnerContribution>They have loaned us equipment and provided privileged discounts for almost 20 years (in kind value well over &amp;pound;100k). They have advised us on new emerging technology. They have assisted by providing staff for our training courses (recent in kind value calculated as &amp;pound;50k. They have provided &amp;pound;10k in cash towards training courses since 2008. A further &amp;pound;4k in cash and &amp;pound;10k has been committed to future training courses.</gtr:partnerContribution><gtr:piContribution>We have advised Hamamatsu on trends in bio-imaging for 20 years. We have provided new data and tested prototype equipment. We have given them an opportunity to display their equipment at our training courses.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK (CRUK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Cancer Research Technologies</gtr:description><gtr:id>2FB23EA2-77B1-4F51-835B-6B117A64CA18</gtr:id><gtr:impact>Early stage of collaboration</gtr:impact><gtr:partnerContribution>Assistance with design of the screen</gtr:partnerContribution><gtr:piContribution>Running of drug screen for novel NF-kB timing modulators.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Collaboration with Glaxo Smithkline</gtr:description><gtr:id>F3D9652D-F654-4487-B3C6-4756A95774F9</gtr:id><gtr:impact>We are only just at the start of this collaborative stage of the project. We are about to discuss detailed arrangements and agreements</gtr:impact><gtr:partnerContribution>GSK are contributing in kind resources and expertise to assist with a new drug screen for compounds that alter NF-kappaB dynamics.</gtr:partnerContribution><gtr:piContribution>We are contributing imaging expertise and knowledge of NF-kappaB signalling</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Warwick</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with University of Warwick</gtr:description><gtr:id>CAFC31E7-C6B9-48DD-84A1-3952E9B8C211</gtr:id><gtr:impact>This multidisciplinary collaboration led to the award of the &amp;pound;5m BBSRC SABR grant between warwick, Liverpool and Manchester. This directly arose from this collaboration with the Warwick group assisting with the predictive modelling work. The collaboration supported the Science paper by Ashall et al., (19359585) In 2010 through more distantly related work, a &amp;pound;1.4m Wellcome trust Programme grant was awarded to Manchester and Warwick. In 2013 a further directly related &amp;pound;3.6m BBSRC sLOLA grant was awarded to Manchester and Warwick.</gtr:impact><gtr:partnerContribution>We have established a strong systems biology collaboration with the Systems Biology Department in Warwick (particularly with Prof. D. Rand). They have become our principal mathematics collaboration and contributed very significantly to our recent Science paper (Ashall et al.,) and other papers submitted or in preparation. This collaboration included the Warwick group (T. Brettschneider) using their own funds to assist us in the development of cell imaging programs through their employment of a post-doc. We also have collaborated over student training.</gtr:partnerContribution><gtr:piContribution>We have shared data and made visits to Warwick to discuss the collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Carl Zeiss AG</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Carl Zeiss</gtr:description><gtr:id>8701EE1D-5F34-47D2-AAAA-0B0251A5C564</gtr:id><gtr:impact>Annual training courses
MICA collaborative MRC grant
MICA collaboration on new single cell centre

The relationship with Zeiss has been two way. We have been given the opportunity to be early adopters f new technology and to feedback idease for improvement. We receive very favourable deals on microscope purchases and maintenance contracts. Specific areas of successful collaboration lie in improvements to higher throughput live cell imaging using the confocal microscopes; optimisation of truly dark microscopes for quantitative luminescence imaging and the development of FCS.

Multiple workshops organised (2-3 per yeat)</gtr:impact><gtr:partnerContribution>Zeiss have made a cash contribution to training courses (received) of &amp;pound;16,250. Zeiss estimate of total value of in-kind staff time for collaboration, training courses and other meetings (including visits of teams from Germany) ?25,000. In addition, Zeiss have also committed over &amp;pound;30,000 in cash and ~&amp;pound;80000 in in kind staff for future training meetings and collaborative visits. 
Zeiss helped to design the new Systems Microscopy Centre in Manchester and made a 45% discount (value ?350k) for the purchase of equipment in 2011. Zeiss are a formal MICA partner on both Liverpool and Manchester awards from the MRC/BBSRC New Microscopy Initiative. In the award to Manchester they have made a contribution of &amp;pound;614,314 in staff time, development costs and equipment contribution. This involves FCS (developed during this project), luminescence fluorescence imaging, light sheet microscopy and SOFI super-resolution imaging. More recently Zeiss have made a further contribution to our new clinical single cell centre. This includes over &amp;pound;400k in equipment discounts and &amp;pound;25k in cash contribution to training and symposia.
Over the years the Zeiss contributions have included them helping us with public understanding of science exhibitions where they loaned equipment, provided support for professional poster preparation and used their delivery services to transport our exhibit materials and equipment to the exhibition venues. This included an exhibition in Buckingham Palace in 2006.
Zeiss have sponsored 2-3 meetings per year in Manchester. In 2016 this included a session on light sheet imaging and a session on new confocal imaging technologies. In 2017 they have sponsored an image analysis daya and will sponsor a single cell biology workshop.</gtr:partnerContribution><gtr:piContribution>We have advised Zeiss on trends in bioimaging since 1996. We have provided new data and tested prototype equipment. We have spoken at Zeiss organised meetings. We have given them an opportunity to display Zeiss equipment at our training courses. We have organised symposia that have been supported by Zeiss. We have held expert discussion meetings to review microscopy trends that have involved senior Zeiss staff</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Integrative Biology</gtr:department><gtr:description>Collaboration with University of Liverpool</gtr:description><gtr:id>1D9CD14F-7A25-477B-BF8D-F0B9F5E310B8</gtr:id><gtr:impact>Multi-disciplinary - including mathematics, translational medicine and proteomics.</gtr:impact><gtr:partnerContribution>Contribution of data and intellectual input on shared BBSRC grant. Collaboration on student training. (This was a continuing collaboration following move of M. White from Liverpool to Manchester)</gtr:partnerContribution><gtr:piContribution>Contribution of data and intellectual input on shared BBSRC grant. Collaboration on student training.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with AstraZeneca</gtr:description><gtr:id>724A1E54-FD08-4AE7-8699-7A8A160A21DB</gtr:id><gtr:impact>Ashall et al (19359585)</gtr:impact><gtr:partnerContribution>We had a longstanding collaboration with AstraZeneca who advise on a number of projects and have made facilities and reagents available to us. As a result of this one AstraZeneca employee was a co-author on our Science paper by Ashall et al. (19359585). This collaboration closed following the closure of the AstraZeneca Charnwood site. Recently we have resetablished this collaboration and in the next few months a senior AstraZeneca employee plans to spend time in our lab learning imaging techniques.</gtr:partnerContribution><gtr:piContribution>We have discussed many aspects of our research with the staff from AstraZeneca, allowing them to help us to develop our research further. We also tested some candidate drugs. We have taken part in joint meetings and presented several seminars at AstraZeneca</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit, (Manchester Grammar School)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>62689EA1-73D0-44AE-9CBF-87156F8B98E3</gtr:id><gtr:impact>Dean Jackson Feb 2017, Science Fair judge for student projects</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>school visit (Xaverian College)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6D9D14BD-5CB6-4949-9D95-5AFEA5583B51</gtr:id><gtr:impact>Dean Jackson - STEM ambassador</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit (Liverpool Life Sciences, University Technical College)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2CDD76FA-EBF6-4C5F-83D9-3ADE50337CF0</gtr:id><gtr:impact>Liverpool Life Sciences UTC is the first school in the UK specialising in Science and Health Care for 14 to 19 year olds. Talk at Liverpool Life Sciences UTC conference on &amp;quot;How Organisms Age&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Schools University Partnership Initiative event representing medical research in Faculty of Life Sciences, Manchester linked to Cancer and Ageing.</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A4EEDA53-722A-4A72-88D2-8641D69FBA0C</gtr:id><gtr:impact>Dean Jackson - General outreach to schools</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>12000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ISSF Research grant</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>06FA4300-C13A-40A1-AF61-91F1B31BB6C2</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>0</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Discovery award: &amp;quot;Capacity Building in Single Cell Inflammation Discovery: Developing the Next Generation of Scientists&amp;quot;</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>531EFDFE-D10A-4F57-856A-C83A41A2C2FC</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>117309</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Development of novel luciferases for real-time monitoring of protein secretion.</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/K013882/1</gtr:fundingRef><gtr:id>7DD8CDD8-A598-499E-BB40-8A0339007962</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>675328</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC project grant</gtr:description><gtr:end>2020-02-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:fundingRef>MR/P011853/1</gtr:fundingRef><gtr:id>4099753B-E7BA-4B70-9753-B8FC437E42AA</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Capital clinical infrastructure for single cell genomics</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F6EA9F60-5048-4841-96CB-39B0D680F7C0</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2158</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ISSF Research Training Grant</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>097820/Z/11/B</gtr:fundingRef><gtr:id>195D38C6-9354-4752-8B33-BA3D311674FB</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35604</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ISSF Research Grant</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>097820/Z/11/B</gtr:fundingRef><gtr:id>51973159-5E81-443D-BFFA-31A112C9B5E1</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30346</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Exploring the link between inflammation and endocrine signalling in the hypothalamus: the role of neuronal dynamics in healthy ageing.</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/L026902/1</gtr:fundingRef><gtr:id>503FD888-85D5-4892-B6C8-7ABB20A1C3A1</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2583208</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Systems Medicine of Chronic Inflammatory Bowel Disease (SYSMEDBIO)</gtr:department><gtr:description>(W Muller, MW, D Jackson, S Schreiber, T Hofer, D Rand, C Troutwein, J Rhodes, M Pierik, N Schpigel, VM dos Santos, A Kel, L Ferguson, B Fuchs). Systems medicine of chronic inflammatory bowel disease.</gtr:description><gtr:end>2017-11-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:fundingRef>305564</gtr:fundingRef><gtr:id>F7EAE853-9859-48B3-A289-5D259066FEA7</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>programme grant</gtr:description><gtr:end>2022-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B55C66D7-2327-4CBE-B5FE-E03C006BE24C</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The work has been presented at multiple international meetings and involves collaborations with instrumentation companies and a major pharmaceutical company 

Work from the project has been presented in schools and museums.</gtr:description><gtr:firstYearOfImpact>2013</gtr:firstYearOfImpact><gtr:id>7E0D933F-C47D-4171-8FC3-3F735E4D6730</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:sector>Education,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have made and characterised transgenic mice that allow us to see movements and changes in the gene expression of NF-kB proteins in living primary cells and tissues. We have observed that the NF-kB signalling system shows oscillatory movement of the NF-kB transcription factor between the cytoplasm and nucleus in a variety of different cell types including fibroblasts, cartilage and gut organoids. The frequency of these movements varies between different cells and in response to different stimuli. This considerable extends previous work that was performed on cell lines.
We have found that temperature affects the frequency of oscillatons in cell lines and in primary cells. We have also shown that the anti-inflammatory drugs and one kinase inhibitor can affect the frequency of NF-kB movement. We have identified the feedback inhibitor as playing a key role in this process and have adapted mathematical models to test this. The role of A20 has been verified experimentally through knock-down.
We have performed a large gene expression screen to identify sets of genes controlled by temperature and timed pulses of different stimuli. We find that pulsed stimuli can activate a different gene expression profile which may reflect what happens in a living organism. We are studying these gene expression profiles to identify potential frequency encoded genes which may have important functions. Initial candidate genes have important roles in key inflammatory processes and many are transcription factors.
During this work we have improved our experimental and theoretical tools for quantitative cell imaging. In particular this has involved fluorescence correlation spectroscopy which gives absolute quantification of protein concentrations and dissociation constants.
We have obtained data that shows that the NF-kappaB response in cartilage may be regulated by the circadian clock.
We have generated additional transgenic mice that express TNFalpha, c-Rel and RelB reporters. These promise to cast further light on the control of the NF-kB system</gtr:description><gtr:exploitationPathways>The work is iikely to provide generic tools and understanding for studies of inflammatory processes in living animals. It is likely to be of interest to the pharmaceutical industry</gtr:exploitationPathways><gtr:id>61EC4ABE-8F6D-41F2-97EA-B0A98E452AAE</gtr:id><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Appointed to Pool of Experts for BBSRC Panels, 2012-2013.</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>608A2929-E37F-498B-8D1F-69238FD7ED05</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership of BBSRC Interdisciplinary Systems Biology Strategy Committee</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>3DAB736C-9CFD-4C92-91B3-9840553DFC3E</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Microbiome</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3AE9CFE9-C0A0-4187-8383-E8B6341573D4</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BBSRC Panel: Enabling Theme 2, the Exploiting New Ways of Working Strategy Panel (ENWW)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E963348D-2FEA-462D-AD54-5CB34E086508</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC/EPSRC TDRI Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F45E82A9-8E8B-4F21-A2F0-FB07B6686243</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>German Virtual Liver Scientific Advisory Board (42m euros programme )</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>06C3EA26-1AED-4786-BA31-4ACBB6CF0792</gtr:id><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.virtual-liver.de/wordpress/en/media/handling-biological-complexity-using-systems-approaches-4/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BBSRC Bioscience for Industry Committee (single meeting for presentation)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>13D4920E-3D52-46E2-A422-0634F5B41EE4</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC Research Equipment Initiative (REI) Review Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>59509506-735E-4483-A5D3-900035055ED4</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC/BBSRC New Microscopy Initiative</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>678CC292-F42D-49CA-B6E4-5FBFCA47619C</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BBSRC Strategy Meeting</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1707127F-F78E-47D1-836A-0476AC77E525</gtr:id><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Wellcome Trust/Wolfson Capital Awards in Biomedical Sciences Committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>827762D3-5109-4679-952C-D7CCBDDE3A29</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Systems Immunology</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9366DDCB-A65B-432A-BE29-DBAD368666B5</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of MRC Doctoral Training Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4C69BE87-92EC-415C-AADB-E2DBB5C7A205</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC Site visit to Imperial Centre for Systems Biology</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F112D90A-B11B-489F-B3CB-D5450C196EDD</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>External Reviewer for FRISYS-ZBSA (Zentrum fur biosystemanalyse), Freiberg, Germany, 26th May 2011.</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>C1F14E9A-FF82-42BB-BE58-FF65A4D441D4</gtr:id><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC Site visit to Oxford Centre for Systems Biology</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>692FFFF1-DDA3-4B85-833A-D0257C834320</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC Tools and Resources Development Fund Panel, Feb 2012.</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E7833BBB-CF64-481F-B2DF-0EBBE4234328</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BBSRC Strategic Tools and Resources Development Fund (sTRDF) Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0D80ADFF-1E14-4F04-88FA-F6760F3AFA61</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Invited to attend Research Sponsors' Consultation Meeting (BBSRC &amp;amp;MRC) on Imaging for the biological and biomedical sciences, 14 May 2012.</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>76750DF7-1881-4645-88B5-0725E68718F7</gtr:id><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of MRC Population and System Medicine Board, 1 April 2012 - 1 April 2016</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EFCCF53E-0173-4DDF-8929-9C1E14116FB6</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Gene expression analysis of TLR4 signalling in RAW 264.7 macrophage cell line</gtr:description><gtr:id>9A31784F-41DD-4E5E-B992-45CE3C48AB5A</gtr:id><gtr:impact>Incasing depth of knowledge</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Transcriptome analysis of macrophage signalling</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3155/</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Secretome analysis of RAW264.7 cells in response to TLR4 agonist</gtr:description><gtr:id>B6435403-95CC-45F7-BC91-481FAF890944</gtr:id><gtr:impact>Resources for use to other researchers</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Secretome analysis of macrophage signalling</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.ebi.ac.uk/pride/archive/projects/PXD001905</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/00A00E3F-96A0-4FB1-94A7-6027245EEB85"><gtr:id>00A00E3F-96A0-4FB1-94A7-6027245EEB85</gtr:id><gtr:title>Signal transduction controls heterogeneous NF-?B dynamics and target gene expression through cytokine-specific refractory states.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dba0d2441f6590a38f374dcb1bc49357"><gtr:id>dba0d2441f6590a38f374dcb1bc49357</gtr:id><gtr:otherNames>Adamson A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D63C56F7-BF8B-4B08-A952-D5177E671F64"><gtr:id>D63C56F7-BF8B-4B08-A952-D5177E671F64</gtr:id><gtr:title>Spatially coordinated dynamic gene transcription in living pituitary tissue.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e785ebe1caadb418083bec7839085582"><gtr:id>e785ebe1caadb418083bec7839085582</gtr:id><gtr:otherNames>Featherstone K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4DEE37CF-EA91-4954-AFD4-E221B5589D26"><gtr:id>4DEE37CF-EA91-4954-AFD4-E221B5589D26</gtr:id><gtr:title>Using constraints and their value for optimization of large ODE systems.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3df5c2e27c2de5e6adef3fbce726937c"><gtr:id>3df5c2e27c2de5e6adef3fbce726937c</gtr:id><gtr:otherNames>Domijan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FA100A32-F551-4D4D-BE86-C0B782121840"><gtr:id>FA100A32-F551-4D4D-BE86-C0B782121840</gtr:id><gtr:title>Quantitative dynamic imaging of immune cell signalling using lentiviral gene transfer.</gtr:title><gtr:parentPublicationTitle>Integrative biology : quantitative biosciences from nano to macro</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ebc1d2c08f8c6f1acd9226ad8cc2a4ec"><gtr:id>ebc1d2c08f8c6f1acd9226ad8cc2a4ec</gtr:id><gtr:otherNames>Bagnall J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1757-9694</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B8C5522C-C536-4F93-B652-97FCFE7294F4"><gtr:id>B8C5522C-C536-4F93-B652-97FCFE7294F4</gtr:id><gtr:title>Glucocorticoid receptor regulates accurate chromosome segregation and is associated with malignancy.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2b8e11abf417df64c2619312c232c8bf"><gtr:id>2b8e11abf417df64c2619312c232c8bf</gtr:id><gtr:otherNames>Matthews LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5F45AE91-FD8A-450F-883C-7F212AE49004"><gtr:id>5F45AE91-FD8A-450F-883C-7F212AE49004</gtr:id><gtr:title>A method of 'speed coefficients' for biochemical model reduction applied to the NF-?B system.</gtr:title><gtr:parentPublicationTitle>Journal of mathematical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a1833ba3985f20db4b901f261315d647"><gtr:id>a1833ba3985f20db4b901f261315d647</gtr:id><gtr:otherNames>West S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0303-6812</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DE7FC973-845B-44D5-AD51-F6086F515269"><gtr:id>DE7FC973-845B-44D5-AD51-F6086F515269</gtr:id><gtr:title>Inflammasome-dependent IL-1? release depends upon membrane permeabilisation.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ebade41247cd450d29273fec33bb39f2"><gtr:id>ebade41247cd450d29273fec33bb39f2</gtr:id><gtr:otherNames>Mart?n-S?nchez F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E23F1AF9-0E9E-496D-BD7C-97BD143FF6EB"><gtr:id>E23F1AF9-0E9E-496D-BD7C-97BD143FF6EB</gtr:id><gtr:title>Catabolic cytokines disrupt the circadian clock and the expression of clock-controlled genes in cartilage via an NF?B-dependent pathway.</gtr:title><gtr:parentPublicationTitle>Osteoarthritis and cartilage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6529a24cc5e31210c44d4493c3f85ab5"><gtr:id>6529a24cc5e31210c44d4493c3f85ab5</gtr:id><gtr:otherNames>Guo B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1063-4584</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/04042B91-F4FC-42A1-882F-8EF443BF4064"><gtr:id>04042B91-F4FC-42A1-882F-8EF443BF4064</gtr:id><gtr:title>An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fbe77509019047feebf5c8d6e8a47b0d"><gtr:id>fbe77509019047feebf5c8d6e8a47b0d</gtr:id><gtr:otherNames>Gibbs J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/422BC6A3-5BF4-412D-AB6C-242334F3BEC2"><gtr:id>422BC6A3-5BF4-412D-AB6C-242334F3BEC2</gtr:id><gtr:title>Understanding the dynamics of Toll-like Receptor 5 response to flagellin and its regulation by estradiol.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/03e3f281f991842a94363c7902ec5bee"><gtr:id>03e3f281f991842a94363c7902ec5bee</gtr:id><gtr:otherNames>Caballero I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AF07BBD1-6A43-489D-9FA1-D23904E59C4D"><gtr:id>AF07BBD1-6A43-489D-9FA1-D23904E59C4D</gtr:id><gtr:title>Anti-inflammatory effects of infliximab in mice are independent of tumour necrosis factor a neutralization.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c2d571dfccdc5028275f4b6a4f186064"><gtr:id>c2d571dfccdc5028275f4b6a4f186064</gtr:id><gtr:otherNames>Assas BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/79E030BA-1484-4A49-97EA-F67FF963854B"><gtr:id>79E030BA-1484-4A49-97EA-F67FF963854B</gtr:id><gtr:title>Dynamic NF-?B and E2F interactions control the priority and timing of inflammatory signalling and cell proliferation.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e0e38be90a63e0284f712d735e9d2194"><gtr:id>e0e38be90a63e0284f712d735e9d2194</gtr:id><gtr:otherNames>Ankers JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A29FDA0E-FE36-4296-BAD4-E6947CD9FDB2"><gtr:id>A29FDA0E-FE36-4296-BAD4-E6947CD9FDB2</gtr:id><gtr:title>A stochastic transcriptional switch model for single cell imaging data.</gtr:title><gtr:parentPublicationTitle>Biostatistics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/26ab0af7bc1a628f24e89599b9126c2b"><gtr:id>26ab0af7bc1a628f24e89599b9126c2b</gtr:id><gtr:otherNames>Hey KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1465-4644</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/334DC548-B158-45BC-9738-B498778E8A78"><gtr:id>334DC548-B158-45BC-9738-B498778E8A78</gtr:id><gtr:title>From measuring noise toward integrated single-cell biology.</gtr:title><gtr:parentPublicationTitle>Frontiers in genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/43306b88df69e9ecc9c8641a7535e180"><gtr:id>43306b88df69e9ecc9c8641a7535e180</gtr:id><gtr:otherNames>Paszek P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1664-8021</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D18F352D-52E0-4AB9-8B3B-B3C1E66ABA34"><gtr:id>D18F352D-52E0-4AB9-8B3B-B3C1E66ABA34</gtr:id><gtr:title>Visualizing and Quantifying Intracellular Behavior and Abundance of the Core Circadian Clock Protein PERIOD2.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f20c045a0b90c43fb878f36974034ddb"><gtr:id>f20c045a0b90c43fb878f36974034ddb</gtr:id><gtr:otherNames>Smyllie NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/15937187-0E65-4B7E-B80A-4C219654FEF5"><gtr:id>15937187-0E65-4B7E-B80A-4C219654FEF5</gtr:id><gtr:title>Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0252a6a01f3ce5c74b8d8cabc7306a9c"><gtr:id>0252a6a01f3ce5c74b8d8cabc7306a9c</gtr:id><gtr:otherNames>Daniels MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/94168366-E6E7-43DC-A97B-44D6A4528D15"><gtr:id>94168366-E6E7-43DC-A97B-44D6A4528D15</gtr:id><gtr:title>Investigating IL-1? Secretion Using Real-Time Single-Cell Imaging.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a7d5b1909d73d7e81a984b50191dc9b3"><gtr:id>a7d5b1909d73d7e81a984b50191dc9b3</gtr:id><gtr:otherNames>Diamond C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/55CDA8F1-ADF4-4BA7-A99E-1B33A59E3527"><gtr:id>55CDA8F1-ADF4-4BA7-A99E-1B33A59E3527</gtr:id><gtr:title>PeTTSy: a computational tool for perturbation analysis of complex systems biology models.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3df5c2e27c2de5e6adef3fbce726937c"><gtr:id>3df5c2e27c2de5e6adef3fbce726937c</gtr:id><gtr:otherNames>Domijan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C3973558-5078-40CE-8464-05FC59DAF368"><gtr:id>C3973558-5078-40CE-8464-05FC59DAF368</gtr:id><gtr:title>Phase locking and multiple oscillating attractors for the coupled mammalian clock and cell cycle.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/28aa316aa4f18f166fd6fb5d018746be"><gtr:id>28aa316aa4f18f166fd6fb5d018746be</gtr:id><gtr:otherNames>Feillet C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/934C4307-B90D-43B2-B10D-36A0DF6064C4"><gtr:id>934C4307-B90D-43B2-B10D-36A0DF6064C4</gtr:id><gtr:title>Stochasticity in the miR-9/Hes1 oscillatory network can account for clonal heterogeneity in the timing of differentiation.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8c09beeeb9d096d06e11f38b0c9d5294"><gtr:id>8c09beeeb9d096d06e11f38b0c9d5294</gtr:id><gtr:otherNames>Phillips NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/K003097/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>A442BF36-F335-483E-9282-F3BB48AC2C47</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Cell biology</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>C23BE70F-1EF6-4CC7-88B0-841CB18DD875</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Genetics &amp; development</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>9BDF80E2-029E-4505-B7EE-DB0FA633E483</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Omic sciences &amp; technologies</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>FB535BD0-E265-4C0A-8532-32DCB83A3951</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Tools, technologies &amp; methods</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>73EF98E1-3FA8-46A0-BE46-00AE16C7D999</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Communication &amp; signalling</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>FEBB49F4-3228-4CBC-98AB-99A078FB98B5</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Functional genomics</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>CC10CC12-1D16-48BD-8F66-6A64A651DEAB</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Gene action &amp; regulation</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>3493671D-A4CF-4197-90A7-3CCFBE1C0627</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Tools for the biosciences</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>